U.S., Jan. 13 -- ClinicalTrials.gov registry received information related to the study (NCT07332429) titled 'Efficacy and Safety of Alcovit in Reducing Blood Alcohol Concentration' on Dec. 30, 2025.
Brief Summary: The goal of this clinical trial is to learn if Alcovit(R) (zeolite clinoptilolite) works to reduce blood alcohol concentration in healthy adults aged 18-70 years who are occasional or moderate alcohol consumers. It will also learn about the safety and tolerability of Alcovit(R). The main questions it aims to answer are:
* Does Alcovit(R) reduce blood alcohol concentration when administered before or after standardized alcoholic beverage consumption compared to placebo?
* What is the rate of alcohol elimination from the blood (m...